What Protocols Should Clinics Follow To Adjust Laser Fluence When Patients Miss Scheduled Sessions For Vitiligo Or Psoriasis Treatments? Key Dose Adjustment Rules

When a patient misses a laser session, do not automatically resume the full schedule or increase fluence. For psoriasis, a one-week gap generally permits resuming the last dose, while a two-week gap calls for a 25% reduction and a three-week gap requires reassessment and restart under the initial dosing protocol. For vitiligo, maintain the prior dose after one missed week unless tenderness was significant, reduce by 50 mJ/cm² after two weeks, and reassess after three weeks.

The longer the interruption, the less appropriate it is to treat the patient as though tissue tolerance and disease status are unchanged. Apply the condition-specific restart rule, then modify the dose according to the patient’s observed erythema, tenderness, blistering, and clinical response.

Why Missed Sessions Require Dose Review

Treatment intervals affect tissue tolerance

Laser fluence should be based on both the elapsed time since the last session and the patient’s response to that session. A longer interruption may change skin tolerance, lesion status, and the relevance of the previous dose.

The missed-session schedule is a starting framework, not a substitute for clinical assessment. The clinician should examine the treatment area before delivering energy.

Tissue response remains the safety check

Review the response during the expected post-treatment window, particularly 12–72 hours after treatment. Mild erythema, plaque thinning, or reduced scaling may support maintaining the dose, whereas significant erythema, pain, tenderness, or blistering requires a reduction or delay.

Do not treat blistered or incompletely healed skin. Avoid overlapping treatment areas or delivering energy twice to the same area during one session.

Psoriasis: Adjusting Fluence After Missed Sessions

One week missed

After a one-week interruption, resume treatment at the last administered fluence, provided the skin has healed and the patient tolerated that dose appropriately.

If the prior session produced more than the intended response—such as moderate to severe erythema or pain—the dose should be reduced rather than automatically repeated.

Two weeks missed

After a two-week interruption, reduce fluence by 25% from the last administered dose.

Reassess the plaques and surrounding skin before treatment. The reduction is intended to limit excessive erythema or thermal injury when tolerance may no longer match the previous schedule.

Three weeks missed

After a three-week interruption, reassess the patient and restart according to the initial psoriasis dosing guidelines.

The restart assessment should consider plaque induration, the anatomical site, prior adverse reactions, and the current clinical severity. Do not treat the patient as being on an uninterrupted maintenance schedule.

Use response-based adjustments

For ongoing psoriasis sessions, the tissue and plaque response should guide subsequent changes. If there is no effect, fluence may be increased by approximately 25%; minimal effect may support an increase of approximately 15%.

Maintain the dose when improvement is appropriate. If moderate to severe erythema or pain develops, reduce fluence by approximately 25% and reassess before the next exposure.

Vitiligo: Adjusting Fluence After Missed Sessions

One week missed

After a one-week interruption, maintain the last administered dose if the patient had an acceptable response and the skin is healed.

If significant tenderness was documented approximately 48 hours after the prior treatment, reduce the dose by 25 mJ/cm² rather than repeating it unchanged.

Two weeks missed

After a two-week interruption, decrease the dose by 50 mJ/cm² from the last administered setting.

Confirm that the treatment area has no persistent tenderness, significant erythema, blistering, or other injury before proceeding.

Three weeks missed

After a three-week interruption, reassess the patient and return to the original vitiligo protocol rules.

The reassessment should account for anatomical sensitivity, repigmentation progress, prior tolerance, and whether the treatment area has changed since the last session.

Account for anatomical sensitivity

Vitiligo fluence should be tailored to the treated site rather than based solely on minimal erythema testing of normal skin. The face, periocular region, trunk, extremities, and hands or feet can have different tolerance and starting-dose requirements.

If there is no clinical effect during regularly scheduled treatments, the dose may be increased by 50 mJ/cm² per session until the intended mild erythema response is reached, subject to the device-specific protocol and clinician judgment.

Moderate erythema generally warrants a 50 mJ/cm² reduction. Severe erythema may require postponing treatment or reducing fluence by 100 mJ/cm².

What to Assess Before Resuming Treatment

Inspect the treated skin

The clinician should confirm that the area is healed and evaluate erythema, tenderness, scaling, blistering, pigmentary change, and other signs of injury. Treatment should be postponed when the skin has not recovered.

A missed appointment is not an indication to compensate by doubling fluence, treating twice in one visit, or compressing multiple sessions into a shorter interval.

Review the prior response

Examine both therapeutic and adverse responses. For psoriasis, document plaque induration, scaling, and improvement; for vitiligo, document repigmentation and the response of the specific anatomical site.

The relevant response may appear after treatment rather than immediately, so patient-reported tenderness and delayed erythema should be incorporated into the decision.

Confirm the treatment area

Record exactly which lesions or body areas will be treated. Avoid overlap with recently treated areas, particularly where boundaries are difficult to identify or where the patient has received other phototherapy or light-based treatment.

Documentation That Supports Safe Adjustments

Record the essential treatment variables

For every session, document:

Fluence and energy settings
Anatomical areas treated
Treated body surface area
Total energy delivered
Treatment date and interval since the prior session
Observed skin response and patient-reported symptoms

This record allows the clinician to calculate the appropriate reduction after a missed session instead of relying on memory or an incomplete device history.

Record the reason for any deviation

If the clinician departs from the standard one-, two-, or three-week rule, document why. Examples include persistent erythema, prior blistering, significant tenderness, unusually sensitive anatomy, or substantial clinical improvement.

Clear documentation also helps maintain consistency when different clinicians treat the same patient.

Understanding the Trade-offs

A conservative reduction may slow progress

Reducing fluence after an interruption can modestly slow treatment response, particularly when disease control depends on frequent sessions. That trade-off is generally preferable to restarting at an excessive dose when tissue tolerance is uncertain.

The objective is not to maximize energy per session, but to deliver a tolerable cumulative treatment course.

Repeating the old dose may be inappropriate

Maintaining the previous fluence after a long gap can increase the risk of excessive erythema, pain, blistering, or post-inflammatory hyperpigmentation. This is why the two- and three-week rules become progressively more conservative.

Disease response can justify further adjustment

Missed-session rules should not override clinical response. Significant plaque improvement may support a 25% reduction in psoriasis treatment fluence, while absent response may justify a carefully monitored increase when the skin has tolerated prior sessions.

Device and protocol differences matter

Fluence values and adjustment increments are not interchangeable across laser systems, wavelengths, spot sizes, pulse structures, or treatment indications. These rules should be applied within the device’s validated protocol and the clinic’s governing clinical guidelines.

How to Apply This to Your Clinic

Use the missed-session rule first, then apply a second safety check based on healing, delayed tissue response, and disease improvement.

If your primary focus is psoriasis: Resume the prior fluence after one missed week, reduce it by 25% after two weeks, and reassess under the initial protocol after three weeks.
If your primary focus is vitiligo: Maintain the prior dose after one missed week unless significant tenderness occurred, reduce by 50 mJ/cm² after two weeks, and reassess under the original protocol after three weeks.
If your primary focus is adverse-event prevention: Delay treatment for blistering or unhealed skin, avoid overlap, and reduce or postpone treatment when severe erythema, pain, or tenderness is present.
If your primary focus is treatment consistency: Record fluence, treated area, body surface area, total energy, treatment interval, and delayed tissue response after every session.

A structured, response-based restart protocol protects patients while preserving the effectiveness of the overall treatment course.

Summary Table:

Missed Time	Psoriasis	Vitiligo
1 week	Resume last fluence	Maintain last dose (reduce 25 mJ/cm² if tender)
2 weeks	Reduce 25%	Reduce 50 mJ/cm²
3 weeks	Reassess and restart initial protocol	Reassess and restart original protocol

Ensure patient safety and optimal outcomes with BELIS's advanced laser systems designed for precision and reliability. Our diode lasers, CO2 fractional, and Nd:YAG devices offer adjustable fluence settings to support your clinic's protocols. Contact our experts today to enhance your practice and elevate patient care. Contact us now to learn more.